Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

WT1 peptide vaccine

Known as: WT-1 vax, WT1 Analog Peptide Vaccine 
A peptide vaccine comprised of an epitope of human Wilms tumor 1 (WT-1) with potential antineoplastic activity. WT-1, a transcription factor, is… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BackgroundThe optimal strategy for vaccination to induce CD8+ T cell responses against WT1 is not known.MethodsA pilot randomized… Expand
  • figure 1
  • table 2
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2017
Review
2017
The identification of human Wilms' tumor gene 1 (WT1) protein-derived cytotoxic T lymphocyte (CTL) epitopes and the in vivo… Expand
  • table 1
Is this relevant?
2017
2017
In this issue of Blood, Tawara et al report the first results of a novel treatment approach with T-cell receptor transduced… Expand
Is this relevant?
2016
2016
Background: Wilms9 tumor gene 1 (WT1), broadly expressed in hematological malignancies and solid tumors, is a promising candidate… Expand
Is this relevant?
2012
2012
ObjectiveThe aim of the present study was to analyze the long-term survival effects of WT1 peptide vaccine, in addition to its… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
2012
2012
To induce and activate tumor-associated antigen-specific cytotoxic T lymphocytes (CTLs) for cancer immunity, it is important not… Expand
Is this relevant?
2006
2006
2511 Background: The transcription factor Wilms tumor protein (WT) 1 belongs to a new generation of tumor antigens, as it is… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
The Wilms' tumor gene WT1 is overexpressed in leukemias and various types of solid tumors, and the WT1 protein was demonstrated… Expand
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • table 2
Is this relevant?